Mostrar el registro sencillo

dc.contributor.authorAlmeida-Santiago, Cristinaes_ES
dc.contributor.authorQuevedo-Abeledo, Juan Carloses_ES
dc.contributor.authorHernández-Hernández, María Vanesaes_ES
dc.contributor.authorVera-González, Antonia dees_ES
dc.contributor.authorGonzález-Delgado, Alejandraes_ES
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel es_ES
dc.contributor.authorFerraz-Amaro, Ivánes_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2023-09-12T15:31:17Z
dc.date.available2023-09-12T15:31:17Z
dc.date.issued2022es_ES
dc.identifier.issn2075-1729es_ES
dc.identifier.urihttps://hdl.handle.net/10902/29872
dc.description.abstractInterleukin-1 receptor antagonist (IL-1ra) concentration reflects and is proportional to IL-1 production. Both IL-1 and IL-6 are involved in the pathogenesis of rheumatoid arthritis (RA). However, the relationship of serum levels of these two cytokines to each other in RA patients is not well-understood. In this study, our objective was to analyze the possible linear correlation between IL-1ra and IL-6 in patients with RA, and how both are related to the inflammatory activity of the disease. IL-6 and IL-1ra levels were measured in 407 patients with RA. Linear regression and partial correlations were conducted to analyze the relationship between both cytokines, and their association with RA characteristics. No correlation was found between serum levels of IL-6 and IL-1ra (Pearson's r 0.031, p = 0.61). However, disease activity and acute phase reactants were positively and significantly associated with both cytokines. Nevertheless, after controlling for covariates, disease activity scores were more strongly associated with IL-1ra compared to IL-6. Circulating IL-6 and IL-1ra do not correlate with each other in RA patients. Although both are associated with disease activity and acute phase reactants, the relationship of disease activity to IL-1ra is greater than that to IL-6.es_ES
dc.description.sponsorshipFunding: This work was supported by a grant to I.F-A. and J.C.Q-A. from Fundación Canaria Instituto de Investigación Sanitaria de Canarias—FIISC (PI19/00012).es_ES
dc.format.extent10 p.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution 4.0 International*
dc.rights© 2022 by the authors*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceLife, 2023, 13, 82es_ES
dc.subject.otherRheumatoid arthritises_ES
dc.subject.otherInterleukin-6es_ES
dc.subject.otherInterleukin-1es_ES
dc.subject.otherInterleukin-1 receptor antagonistes_ES
dc.subject.otherDisease activityes_ES
dc.titleDisease activity is more associated with IL-1 than with IL-6 in patients with rheumatoid arthritises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3390/life13010082es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International